Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment with an oxazolidinone antibiotic inhibits toxic shock syndrome toxin-1 production in MRSA-infected burn wounds.

Shupp JW, Ortiz RT, Moffatt LT, Jo DY, Randad PR, Njimoluh KL, Mauskar NA, Mino MJ, Amundsen B, Jordan MH. Treatment with an oxazolidinone antibiotic inhibits toxic shock syndrome toxin-1 production in MRSA-infected burn wounds. J Burn Care Res. 2013 Mar-Apr; 34(2):267-73.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.